21 Jan 2020  |  North America
The Market is Underpenetrated but has the Potential to Reach $9.4 Billion by 2024
Femtech is an emerging term and, as is the case with most new concepts, is poorly understood. While some relate Femtech only with products unique to the female anatomy (including consumer products), others dismiss it as just another term for a group of existing solutions. Frost & Sullivan believes it is a unique space and a place for new growth opp...
05 Sep 2019  |  Global
Growth Opportunities to Boost Revenue in this Slowing Industry by an Additional $240 Billion by 2024
The medtech industry’s revenue growth is expected to gradually dip beyond 2020, from a year-on-year growth of about 5.7% in 2020 to 5.3% in 2024. The industry is already addressing this as well as several other challenges such as the changing device ecosystem, shifting competitive focus, and the invasion by technology companies. Medtech players a...
03 May 2019  |  North America
Analysis of the US and EU5 Hospital Operating Room (OR) Products and Solutions Market, Forecast to 2022
Transforming OR Product Lines to OR Efficacy Solutions
The key issue being debated in the healthcare industry today is how to transform a seemingly simple operating room (OR) into a technology-fueled, infection-free, and sleek surgical environment. A true smart hospital focuses on 3 major areas, namely, operational efficiency, clinical excellence, and patient-centricity, with technological advancements...
27 Apr 2018  |  North America
Strategies for MedTech MNCs to meaningfully use technology developments to win in emerging markets
MedTech markets are among the most competitive markets worldwide, which are largely dominated by large multinational companies offering a wide range of products and solutions for top diseases. Emerging markets are vital to sustainable business growth and performance of top multinational companies, especially due to the huge patient turnover rates a...
USD 4,207.50 save 15 %